Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 3
2015 1
2016 1
2018 1
2019 2
2020 1
2021 1
2022 2
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) Biobank.
Martel A, Gastaud L, Bonnetaud C, Nahon-Esteve S, Washetine K, Bordone O, Salah M, Tanga V, Fayada J, Lespinet V, Allegra M, Lalvee S, Zahaf K, Baillif S, Bertolotto C, Mograbi B, Lassalle S, Hofman P. Martel A, et al. Among authors: zahaf k. Cancers (Basel). 2023 Apr 19;15(8):2372. doi: 10.3390/cancers15082372. Cancers (Basel). 2023. PMID: 37190299 Free PMC article. Review.
Assessment of Different Circulating Tumor Cell Platforms for Uveal Melanoma: Potential Impact for Future Routine Clinical Practice.
Martel A, Mograbi B, Romeo B, Gastaud L, Lalvee S, Zahaf K, Fayada J, Nahon-Esteve S, Bonnetaud C, Salah M, Tanga V, Baillif S, Bertolotto C, Lassalle S, Hofman P. Martel A, et al. Among authors: zahaf k. Int J Mol Sci. 2023 Jul 4;24(13):11075. doi: 10.3390/ijms241311075. Int J Mol Sci. 2023. PMID: 37446253 Free PMC article.
Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a southern French patient cohort.
Lamas NJ, Lassalle S, Martel A, Nahon-Estève S, Macocco A, Zahaf K, Lalvee S, Fayada J, Lespinet-Fabre V, Bordone O, Pedeutour F, Baillif S, Hofman P. Lamas NJ, et al. Among authors: zahaf k. Pathology. 2023 Dec;55(7):929-944. doi: 10.1016/j.pathol.2023.08.003. Epub 2023 Sep 22. Pathology. 2023. PMID: 37863710 Free article.
Analytical validation of automated multiplex chromogenic immunohistochemistry for diagnostic and predictive purpose in non-small cell lung cancer.
Ilié M, Beaulande M, Long-Mira E, Bontoux C, Zahaf K, Lalvée S, Hamila M, Benzaquen J, Cohen C, Berthet JP, Marquette CH, Lassalle S, Hofman V, Hofman P. Ilié M, et al. Among authors: zahaf k. Lung Cancer. 2022 Apr;166:1-8. doi: 10.1016/j.lungcan.2022.01.022. Epub 2022 Feb 3. Lung Cancer. 2022. PMID: 35134710
Comparison of Two Rapid Assays for the Detection of BRAF V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes.
Long-Mira E, Picard-Gauci A, Lassalle S, Hofman V, Lalvée S, Tanga V, Zahaf K, Bonnetaud C, Lespinet V, Camuzard O, Montaudié H, Poissonnet G, Passeron T, Ilié M, Hofman P. Long-Mira E, et al. Among authors: zahaf k. Diagnostics (Basel). 2022 Mar 19;12(3):751. doi: 10.3390/diagnostics12030751. Diagnostics (Basel). 2022. PMID: 35328303 Free PMC article.
Lack of correlation between MET and PD-L1 expression in non-small cell lung cancer revealed by comparative study of matched biopsies and surgical resection samples.
Ilié M, Hofman V, Bontoux C, Goffinet S, Benzaquen J, Heeke S, Boutros J, Lassalle S, Long-Mira E, Zahaf K, Lalvée S, Lespinet-Fabre V, Bordone O, Tanga V, Gómez-Caro A, Cohen C, Berthet JP, Marquette CH, Hofman P. Ilié M, et al. Among authors: zahaf k. Lung Cancer. 2023 Jul;181:107230. doi: 10.1016/j.lungcan.2023.107230. Epub 2023 May 4. Lung Cancer. 2023. PMID: 37150140
Effect of mutant variants of the KRAS gene on PD-L1 expression and on the immune microenvironment and association with clinical outcome in lung adenocarcinoma patients.
Falk AT, Yazbeck N, Guibert N, Chamorey E, Paquet A, Ribeyre L, Bence C, Zahaf K, Leroy S, Marquette CH, Cohen C, Mograbi B, Mazières J, Hofman V, Brest P, Hofman P, Ilié M. Falk AT, et al. Among authors: zahaf k. Lung Cancer. 2018 Jul;121:70-75. doi: 10.1016/j.lungcan.2018.05.009. Epub 2018 May 26. Lung Cancer. 2018. PMID: 29858030
Multicenter Evaluation of a Novel ROS1 Immunohistochemistry Assay (SP384) for Detection of ROS1 Rearrangements in a Large Cohort of Lung Adenocarcinoma Patients.
Hofman V, Rouquette I, Long-Mira E, Piton N, Chamorey E, Heeke S, Vignaud JM, Yguel C, Mazières J, Lepage AL, Bibeau F, Begueret H, Lassalle S, Lalvée S, Zahaf K, Benzaquen J, Poudenx M, Marquette CH, Sabourin JC, Ilié M, Hofman P. Hofman V, et al. Among authors: zahaf k. J Thorac Oncol. 2019 Jul;14(7):1204-1212. doi: 10.1016/j.jtho.2019.03.024. Epub 2019 Apr 15. J Thorac Oncol. 2019. PMID: 30999109 Free article.
Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France).
Lassalle S, Hofman V, Heeke S, Benzaquen J, Long E, Poudenx M, Lantéri E, Boutros J, Tanga V, Zahaf K, Lalvée S, Lespinet V, Bordone O, Félix JM, Bonnetaud C, Marquette C, Ilie M, Hofman P. Lassalle S, et al. Among authors: zahaf k. Cancers (Basel). 2020 Apr 13;12(4):955. doi: 10.3390/cancers12040955. Cancers (Basel). 2020. PMID: 32294880 Free PMC article.
16 results